FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved Fresenius Kabi USA's supplemental application for fluphenazine decanoate, a long-acting injectable antipsychotic, indicating an approved change…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Fluphenazine decanoate (Fluphenazine decanoate)

Snippet

SUPPL AP for FLUPHENAZINE DECANOATE (FLUPHENAZINE DECANOATE)